SMARCA1 and cancer: While ARID1A mutations are known to contribute to cancer through the disruption of the SWI/SNF chromatin remodeling complex, the novel variants identified in this study suggest that there may be additional, uncharacterized mechanisms by which ARID1A loss contributes to tumorigenesis [25].